We are live on ! Find out more
KURA icon

Kura Oncology
KURA

76 hedge funds and large institutions have $299M invested in Kura Oncology in 2017 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 6

150% more call options, than puts

Call options by funds: $5K | Put options by funds: $2K

15% more funds holding

Funds holding: 66 → 76 (+10)

13% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 23

3% more capital invested

Capital invested by funds: $290M → $299M (+$8.64M)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

5.48% less ownership

Funds ownership: 70.13% → 64.64% (-5.5%)

Holders
76
Holders Change
+10
Holders Change %
+15.15%
% of All Funds
1.72%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
16
Increased
26
Reduced
23
Closed
6
Calls
$5K
Puts
$2K
Net Calls
+$3K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.4M
2
GPP
Great Point Partners
Connecticut
+$6.58M
3
Morgan Stanley
Morgan Stanley
New York
+$2.97M
4
NC
Nexthera Capital
New York
+$2.76M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$2.55M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$9.72M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.45M
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$5.79M
4
Renaissance Technologies
Renaissance Technologies
New York
-$2.61M
5
Deutsche Bank
Deutsche Bank
Germany
-$2.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
AWM
76
Avior Wealth Management
Nebraska
$1K – – –
IHM
77
Iguana Healthcare Management
New York
– -$1.35M -90,000 Closed
VF
78
Virtu Financial
New York
– -$1.03M -68,658 Closed
NFA
79
Nationwide Fund Advisors
Ohio
– -$643K -42,981 Closed
EMG
80
Ellington Management Group
Connecticut
– -$212K -14,200 Closed
CS
81
Credit Suisse
Switzerland
– -$190K -12,761 Closed
TRCT
82
Tower Research Capital (TRC)
New York
– -$2K -136 Closed
1 2 3
4

KURA Hedge Fund Activity: Q4 2017 in Review

76 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2017, worth a combined $299M — up 3% from $290M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new KURA positions and 6 closed out — a net gain of 10 holders — while 26 added to existing stakes and 23 trimmed.

The largest buyer was BlackRock, adding an estimated $7.4M. The largest seller was PFM Health Sciences, cutting an estimated $9.72M.

  • 76 institutional investors held Kura Oncology (KURA) as of Q4 2017, up from 66 in Q3 2017.
  • Funds reported $299M of Kura Oncology stock for Q4 2017, up 3% quarter-over-quarter.
  • 16 funds opened new Kura Oncology positions in Q4 2017 and 6 closed out, a net change of +10 holders.
  • The largest Kura Oncology buyer in Q4 2017 was BlackRock, an estimated $7.4M added.
  • The largest Kura Oncology seller in Q4 2017 was PFM Health Sciences, an estimated $9.72M sold.

Based on aggregated 13F filings for Q4 2017.